ERBB2 and breast cancer: Although cancer treatment has reached the era of precision medicine, the precise treatment of BC remains a challenge, because no effective targets have been found except for a few validated biomarkers, such as estrogen receptor (ER), HER2, PIK3CA, and AKT1.